Form 4: Invivyd Director Srishti Gupta Reports Stock Option Grant

Director Srishti Gupta reports the acquisition of stock options in Invivyd, Inc.

Summary

• Srishti Gupta, a director of Invivyd, Inc., filed a Form 4 with the SEC.
• The filing reports a transaction that occurred on May 21, 2024.
• Gupta was granted stock options to purchase 100,000 shares of Invivyd's common stock at an exercise price of $2.21.
• The options vest over a three-year period, starting with one-third vesting on the first anniversary of the grant date, and the remainder vesting monthly thereafter, contingent upon continuous service.

Sentiment

Score: 6

Explanation: The document is a routine regulatory filing related to executive compensation. It doesn't contain information that would significantly impact investor sentiment positively or negatively.

Positives

• The grant of stock options aligns the director's interests with those of the shareholders, incentivizing her to work towards the company's success.
• The vesting schedule encourages long-term commitment from the director.

Future Outlook

The document does not contain specific forward-looking statements about the company's future performance, but the stock option grant suggests an expectation of continued service and contribution from the director.

Industry Context

Stock option grants are a common form of executive compensation in the biotechnology industry, used to attract and retain talent and align their interests with those of shareholders. This filing reflects standard practice.

Comparison to Industry Standards

• Stock option grants are a typical component of compensation packages for directors and executives in publicly traded companies, particularly in the biotech sector.
• The vesting schedule of three years with a combination of cliff and monthly vesting is also a common structure to incentivize long-term commitment.
• Comparable companies in the biotech industry often use similar equity-based compensation to align management and shareholder interests.

Stakeholder Impact

• The stock option grant could have a minor positive impact on shareholder sentiment as it aligns the director's interests with those of the shareholders.

Key Dates